COVID-19
Regístrese
Enfermedades Infecciosas y Microbiología Clínica
Suscribe to the journal
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A...
Journal Information
Back to article

Statistics

Follow this link to access the full text of the article

Original article
Ceftolozane/tazobactam for the treatment of Pseudomonas aeruginosa infections: A multicenter case series analysis
Ceftolozano/tazobactam para el tratamiento de infecciones por Pseudomonas aeruginosa: una serie de casos multicéntrica
Inês Leonor Leitãoa,b, Carla Mimoso Santosa,b,
Corresponding author
carla.mimoso.santos@gmail.com

Corresponding author.
, Paulo Andréc, Sara Linob,d, Marcos Lemose, Filipe Froesf
a Infectious Diseases Department, Santa Maria Hospital – Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
b Infectious Diseases Clinic, Lisbon University Faculty of Medicine, Lisbon, Portugal
c Intensive Care Unit, Centro Hospitalar Barreiro-Montijo, Barreiro, Portugal
d Infectious Diseases Department, Curry Cabral Hospital – Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal
e Clinical Hematology Department, Santo António dos Capuchos Hospital – Centro Hospitalar Universitário Lisboa Central, Lisbon, Portugal
f Chest Department, Pulido Valente Hospital – Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
Read
710
Times
was read the article
167
Total PDF
543
Total HTML
Share statistics
Article information
ISSN: 0213005X
Original language: English
DOI:10.1016/j.eimc.2021.12.008
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 35 2 37
2024 April 87 11 98
2024 March 14 2 16
2024 February 6 5 11
2024 January 17 4 21
2023 December 9 1 10
2023 November 41 3 44
2023 October 327 107 434
2023 August 1 2 3
2023 March 5 2 7
2023 February 0 2 2
2022 September 0 2 2
2022 May 1 2 3
2022 March 0 8 8
2022 February 0 14 14
Show all

Follow this link to access the full text of the article

Subscribe to our newsletter

Publish in
Enfermedades Infecciosas y Microbiología Clínica
Special content about COVID-19
Free access articles
Infección bacteriana/fúngica en pacientes con...
Enferm Infecc Microbiol Clin. 2022;40:158-65
Eosinofilia y dolor abdominal tras una neumonía grave...
Enferm Infecc Microbiol Clin. 2021;39:478-80
Síndrome febril al regreso del trópico durante la...
Enferm Infecc Microbiol Clin. 2021;39:477-8


La Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica agradece la colaboración de:

SOCIOS PROTECTORES

    - Pfizer GEP, S.L.U.
    - Shionogi, S.L.U.
    - AbbVie Spain, S.L.U.
    - Gilead Sciences, S.L.U.
    - Vircell Spain, S.L.U.
    - Roche Diagnostics, S.L.U.
    - ASTRAZENECA FARMACÉUTICA SPAIN, S.A.
    - Qiagen Iberia S.L.
    - Laboratorios ViiV Healthcare, S.L.

SOCIOS PATROCINADORES

- Becton Dickinson S.A.U.
- Janssen-Cilag, S.A.
- Angelini Farmacéutica, S.A.
- Biomerieux España, S,A.U.
- Merck Sharp & Dohme de España, S.A.
- Hologic Iberia, S.L.U.
- Laboratorios Menarini S.A.
- Accelerate Diagnostics S.L.
- Abbott Laboratories, S.A.
- Cepheid Iberia S.L.U.
- Illumina Productos de España. S.L.U.
- DiaSorin Iberia, S.A.
- GlaxoSmithKline, S.A.
- Sysmex España S.L.

Enfermedades Infecciosas y Microbiología Clínica follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals

es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos